Beyond ACEis and ARBs: The Promise of SGLT2 Inhibition to Reduce Risk of ESRD and Dialysis in Numerous Patient Populations

Access Activity

Overview / Abstract:

Target Audience
This activity is designed to meet the educational needs of dermatologists. This education may also be of interest to pediatric dermatologists, dermatology advanced practice providers (NPs and PAs), and dermatology nurses as clinicians who are responsible for the primary diagnosis and treatment of patients with AA.

Program Overview
Alopecia areata is an autoimmune disease that targets the hair follicles, typically causing hair loss on the scalp but also on other areas such as the beard and eyebrows. There are many complexities associated with the development and progression of alopecia areata and patients with alopecia may experience periods of hair regrowth and hair loss throughout the course of the disease. In the final activity in this series, you will hear from two patients with specific challenges related to the management of alopecia areata.

Alopecia Areata Resources
Medical Professionals Toolkit https://www.naaf.org/medical-professionals-toolkit
What You Should Know Brochure https://www.naaf.org/sites/default/files/documents/pdf/37728_naaf_wysk-6p_proof.pdf
Helping You Cope https://www.naaf.org/sites/default/files/documents/pdf/36529_naaf_coping-4p_teal01drk_proof.pdf
A Parent’s Guide https://www.naaf.org/sites/default/files/documents/pdf/34393_naaf_parent-5p_proof.pdf
From a Child’s Point of View Brochure https://www.naaf.org/medical-professionals-toolkit
Medical Professionals Toolkit https://www.naaf.org/sites/default/files/documents/pdf/34393_naaf_childspov-6p_proof.pdf

Learning Objectives
Upon completion of this activity, participants should be better able to:

Identify the key characteristics that drive the development of alopecia areata, focusing specifically on immunologic pathways that differentiate the condition from other types of hair loss
Assess the emotional and psychological burden associated with alopecia areata that may help quickly uncover core quality-of-life issues to be resolved by the patient and healthcare team during routine visits
Review recent data related to current and emerging therapies, such as JAK/TEC inhibitors, for the treatment of alopecia areata

Expiration

Dec 05, 2023

Discipline(s)

Physician CME

Format

Online

Credits / Hours

0.50 AMA PRA Category 1 Credit(s)™

Accreditation

ACCME

Presenters / Authors / Faculty

Faculty
Amy Fox, MD
Associate Professor
Department of Dermatology
University of North Carolina School of Medicine
Chapel Hill, NC

Brittany Craiglow, MD
Adjunct Assistant Professor
Department of Dermatology
Yale University School of Medicine
New Haven, CT

Sponsors / Supporters / Grant Providers

Pfizer, Inc.

Keywords / Search Terms

Relias LLC Relias LLC., FreeCME., Dialysis Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map